Therefore, in addition to causing cortical seizure activity, Dravet syndrome-associated Scn1a mutations may disrupt the inhibitory modulation of RTN chemoreception. Here, SCN1A is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.